ES452021A1 - Fluidized bed waste incineration process - Google Patents

Fluidized bed waste incineration process

Info

Publication number
ES452021A1
ES452021A1 ES452021A ES452021A ES452021A1 ES 452021 A1 ES452021 A1 ES 452021A1 ES 452021 A ES452021 A ES 452021A ES 452021 A ES452021 A ES 452021A ES 452021 A1 ES452021 A1 ES 452021A1
Authority
ES
Spain
Prior art keywords
antibiotic
mixture
factors
fluidized bed
waste incineration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES452021A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES452021A1 publication Critical patent/ES452021A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A process for the preparation of the antibiotic A-30912 mixture which contains the seven factors A, B, C, D, E, F and G is described. This antibiotic mixture is obtained by cultivating an Aspergillus rugulosus which has the deposition number NRRL 8113 under aerobic submerged fermentation conditions in a nutrient medium which contains substances providing assimilable carbohydrates, nitrogen and inorganic salts. As soon as a significant antibiotic activity has formed, the antibiotic mixture is isolated from the fermentation medium. Each of the 7 factors A to G can be isolated individually from this antibiotic A-30912 mixture. The antibiotic A-30912 mixture and the individual factors contained therein have antifungal activity and they can be employed, in particular, as active substances in compositions for controlling fungal diseases of the skin.
ES452021A 1975-10-02 1976-09-30 Fluidized bed waste incineration process Expired ES452021A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61910775A 1975-10-02 1975-10-02

Publications (1)

Publication Number Publication Date
ES452021A1 true ES452021A1 (en) 1977-12-01

Family

ID=24480483

Family Applications (1)

Application Number Title Priority Date Filing Date
ES452021A Expired ES452021A1 (en) 1975-10-02 1976-09-30 Fluidized bed waste incineration process

Country Status (28)

Country Link
JP (1) JPS5242801A (en)
AR (1) AR209993A1 (en)
AT (1) AT346479B (en)
AU (1) AU506777B2 (en)
BE (1) BE846829A (en)
BG (1) BG25380A3 (en)
CA (1) CA1080145A (en)
CH (1) CH629531A5 (en)
CS (1) CS212776B2 (en)
DD (1) DD127442A5 (en)
DE (1) DE2643485A1 (en)
DK (1) DK143608C (en)
ES (1) ES452021A1 (en)
FR (1) FR2326200A1 (en)
GB (2) GB1499710A (en)
GR (1) GR61730B (en)
HU (1) HU173445B (en)
IE (1) IE43663B1 (en)
IL (1) IL50429A (en)
NL (1) NL7610808A (en)
NZ (1) NZ182123A (en)
PL (1) PL103996B1 (en)
PT (1) PT65617B (en)
RO (1) RO69985A (en)
SE (1) SE7610943L (en)
SU (1) SU620215A3 (en)
YU (1) YU236076A (en)
ZA (1) ZA765320B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5452797A (en) * 1977-10-04 1979-04-25 Meiji Seika Kaisha Ltd Novel antibiotic substance bn-200, and its preparation
CA1170598A (en) * 1979-12-13 1984-07-10 Bernard J. Abbott Process for the preparation of cyclic peptide nuclei
GB2180464A (en) * 1985-09-18 1987-04-01 British Gas Corp Gas-solid phase reactions and apparatus therefor
FI76004B (en) * 1986-03-24 1988-05-31 Seppo Kalervo Ruottu CIRKULATIONSMASSAREAKTOR.

Also Published As

Publication number Publication date
IE43663L (en) 1977-04-02
IL50429A0 (en) 1976-11-30
DK143608C (en) 1982-02-15
AT346479B (en) 1978-11-10
DK143608B (en) 1981-09-14
FR2326200A1 (en) 1977-04-29
GR61730B (en) 1978-12-30
CH629531A5 (en) 1982-04-30
HU173445B (en) 1979-05-28
IL50429A (en) 1979-11-30
BG25380A3 (en) 1978-09-15
ZA765320B (en) 1978-04-26
IE43663B1 (en) 1981-04-22
BE846829A (en) 1977-04-01
NZ182123A (en) 1978-06-02
CA1080145A (en) 1980-06-24
AU1808076A (en) 1978-04-06
DE2643485A1 (en) 1977-04-14
DD127442A5 (en) 1977-09-21
AU506777B2 (en) 1980-01-24
ATA730976A (en) 1978-03-15
CS212776B2 (en) 1982-03-26
PT65617A (en) 1976-10-01
PL103996B1 (en) 1979-07-31
JPS5242801A (en) 1977-04-04
GB1499710A (en) 1978-02-01
DK440276A (en) 1977-04-03
YU236076A (en) 1983-04-30
AR209993A1 (en) 1977-06-15
SU620215A3 (en) 1978-08-15
RO69985A (en) 1981-05-15
NL7610808A (en) 1977-04-05
SE7610943L (en) 1977-04-03
GB1565821A (en) 1980-04-23
FR2326200B1 (en) 1980-03-07
PT65617B (en) 1978-04-05

Similar Documents

Publication Publication Date Title
ES466791A1 (en) Physiologically active substance esterastin
ES419160A1 (en) Rapamycin and process of preparation
NO893021L (en) PROCEDURE FOR PREPARING A BIOLOGICAL ACTIVE COMPOUND, FR 901228.
JPS5492909A (en) New aminosaccharide and its preparation
EP0207763A3 (en) L-ascorbic acid production in microorganisms
GB1491266A (en) Anti-tumor antibiotics aclacinomycins a and b
ES485074A1 (en) Mixture of antibiotics designated by A-21978, process for its production, their pharmaceutical compositions and producing microorganism.
ES2010143A6 (en) A new process for obtainment of Z(2R,5R)-3-(2-hydroxyethyliden)-7-oxo-4-oxa-1-azabicyclo(3,2,0)-heptane-2-carboxylic acid and pharmaceutically acceptable salts and esters thereof, from fermentation broths of Streptomyces sp.
EP0311194A3 (en) Process for antifungal fermentation product and culture
ES485566A1 (en) Process for the production of a substance having bacteriostatic activity
GB1510847A (en) Process for the production of saccharified starch product
JPS6438049A (en) Antimicrobial agent for human or animal
GB1523835A (en) Process for maximising the growth and nicotine degrading activity of microorganismus
JPS5547630A (en) Optical resolution of phosphorus-containing amino acid
ES452021A1 (en) Fluidized bed waste incineration process
MY100478A (en) Antitumor antibiotic compound
ES8104411A1 (en) Antitumor antibacterial agents
GB1500965A (en) Cyclic ether antibiotics
ES443463A1 (en) Antibiotic complex Bu 2183
ES471709A1 (en) Antibiotic compounds
ES482443A1 (en) Antibiotic KA-7038 and compositions containing same
JPS5540723A (en) Soil activator and its preparation
ES434945A1 (en) 2-Chloroethanephosphonic acid derivatives
ES485529A1 (en) Ravidomycin, process of preparation and pharmaceutical compositions containing same.
SE8003858L (en) PROCEDURE FOR MANUFACTURING BAKERY CELLS WITH HIGH CONTENT OF ACETATKINAS